The largest database of trusted experimental protocols
> Disorders > Sign or Symptom > Photophobia

Photophobia

Photophobia is a condition characterized by an abnormal sensitivity or intolerance to light.
It can be caused by various underlying medical conditions, such as migraines, dry eye syndrome, or ocular disorders.
Individuals with photophobia may experience discomfort, pain, or even visual disturbances when exposed to bright light, natural or artificial.
Proper diagnosis and management of photophobia is important to improve quality of life and enable patients to function comfortarby in their daily activities.
Reserach in this area aims to better understand the underlying mechanisms and develope effective treatment options for those affected by this debilitating condition.

Most cited protocols related to «Photophobia»

MI data were collected on a normal human forearm over a 72×48 mm field of view. Four evenly spaced spatial frequencies between 0 and 0.15 mm−1 were collected and analyzed. The imaging system was identical to that described earlier, except for the inclusion of a 640±10 nm bandpass detection filter and crossed linear polarizers, which reject specular reflection from rough surfaces and maximize our sensitivity to the diffuse component of the light. In idealized liquid phantom experiments, we have performed measurements with and without crossed polarizers and found the difference in recovered optical properties to be typically less than 2 to 3%.
In order to demonstrate the sensitivity of our system to physiological perturbations, we performed a standard venous occlusion study on a 29×40 mm region of the volar forearm. Measurements were performed at a wavelength of 800±10 nm, near the hemoglobin isosbestic point of 805 nm. Measured changes in absorption at this wavelength are insensitive to oxygenation and therefore reflect only that of total hemoglobin. Multifrequency reflectance data at 0 and 0.135 mm−1 were acquired every 4 s for a period of 13 min. After 2.5 min of baseline acquisition, an arm cuff was pressurized to 100 mm Hg for 6.5 min and subsequently released at minute 9.
Publication 2009
Cell Respiration Dental Occlusion Elbow Forearm Hemoglobin Homo sapiens Hypersensitivity Photophobia physiology Reflex Veins
Participants were asked on the baseline questionnaire: “Have you ever had migraine headaches?” and “In the past year, have you had migraine headaches?” From this information, we categorized women into “any history of migraine;” “active migraine,” which includes women with self-reported migraine during the past year; and “prior migraine,” which includes women who reported ever having had a migraine but none in the year prior to completing the questionnaire. Participants who reported active migraine were asked details about their migraine attacks. In a previous study of the WHS (5 (link)), we have shown good agreement with modified 1988 International Headache Society (IHS) criteria for migraine (ICHD-I) (3 ).
The detailed migraine-specific questionnaire contained questions addressing age at migraine onset, physician diagnosis of migraine, family history of migraine, details about migraine attacks, and medication used. Questions about migraine characteristics allowed us to classify women according to the revised 2004 IHS criteria for migraine (ICHD-II) (4 (link)). In particular, women were asked about the frequency of attacks during the past year (daily, weekly, every other week, monthly) – criterion A; usual duration of migraines during the past year (<4 hours, 4–24 hours, 25–48 hours, 49–72 hours, >72 hours) – criterion B; usual location of migraines (unilateral or behind one eye, front of head, back of head, whole head) – criterion C1; usual character of migraines (pounding, pulsating, crushing, sharp, aching, burning) – criterion C2; usual severity of migraines during the past year (light, moderate, severe) – criterion C3; if migraines were triggered or made worse by any physical activity (yes, no) – criterion C4; nausea and/or vomiting (never, sometimes, always) – criterion D1; light sensitivity (never, sometimes, always) – criterion D2; sensitivity to sound (never, sometimes, always) – criterion D2.
Publication 2008
BAD protein, human Character Diagnosis Head Headache Hypersensitivity Light Migraine Disorders Nausea Pharmaceutical Preparations Photophobia Physicians Sound Woman

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2010
Allodynia Chest Complex Regional Pain Syndromes Congenital Abnormality Diagnosis Face Lower Extremity Pain Patients Photophobia Signs and Symptoms Teaching Touch

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2009
ARID1A protein, human Avalanches Cortex, Cerebral Cranium Cross Reactions Extinction, Psychological Head Hemoglobin Hemoglobin A Hypersensitivity Inversion, Chromosome Light Oxyhemoglobin Photophobia Pulse Rate Reconstructive Surgical Procedures Scalp Spectrum Analysis

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2015
Alzheimer's Disease Brain Injuries Corneal Diseases Dark Adaptation Diabetes Mellitus Diagnosis Eligibility Determination Ethics Committees, Research Eye Eye Disorders Fingers Forehead Glaucoma Head Hypersensitivity Infrared Rays Lens, Crystalline Light Macula Lutea Mental Disorders Meridians Neural-Optical Lesion Parkinson Disease Patients Phenylephrine Hydrochloride Photophobia Primary Health Care Pupil Retina Retinal Diseases Tropicamide Visual Acuity

Most recents protocols related to «Photophobia»

We retrospectively collected demographic data (age, sex, height, and weight), medical history (psychiatric, gastrointestinal, vascular, hormonal, cancer, respiratory, and immuno-rheumatologic), and the following headache characteristics: onset age, family history of headache, migraine characteristics (unilateral pain, pulsating pain, or aggravation by routine physical activity), pain intensity (0–10; numerical rating scale [NRS]), associated symptoms (photophobia, phonophobia, and nausea/vomiting; none, mild, moderate, or severe), and the presence of aura. The headache specialist explained the criteria for migraine based on the ICHD-3 to all patients who were asked to track headache and migraine days (including probable migraine days). Patients completed a questionnaire on monthly migraine days (MMD), monthly headache days (MHD), monthly acute medication intake days (AMD) at baseline and MMD after 3 months of treatment. A month was defined as 28 days. The headache specialist verified the accuracy and reliability of the completed questionnaire by interviewing and occasionally reviewing each patient’s headache diary. Patients were classified as having episodic migraine or chronic migraine, according to the ICHD-3. Patients were also diagnosed with MOH based on the ICHD-3. Patients completed the Generalized Anxiety Disorder-7 (GAD-7) questionnaire [27 (link), 28 ] and Patient Health Questionnaire-9 (PHQ-9) [29 (link)] upon CGRPmAb administration to determine the extent of anxiety and depression, respectively. We also collected patient migraine-preventive drug data, including failures of preventative drugs (lomerizine, propranolol, valproate, amitriptyline, or topiramate) before CGRPmAb treatment and response frequency to triptan (0, 1, 2, 3 out of three uses) [10 (link)].
Publication 2023
Amitriptyline Anxiety Headache Hematologic Neoplasms lomerizine Migraine Disorders Nausea Pain Patients Pharmaceutical Preparations Phonophobia Photophobia Propranolol Respiratory Rate Severity, Pain Topiramate Triptans Valproate
We calculated the percentage reduction in MMD from baseline after 3 months of treatment. We assessed the characteristics of patients who responded with ≥ 25%, 50%, and 75% reduction in MMD by comparing the average scores between responders and non-responders for the following items: patient characteristics (age, onset age, sex, and body mass index [BMI]), diagnosis (episodic or chronic, presence of aura), migraine characteristics (unilateral/bilateral, pulsating/non-pulsating, pain intensity on NRS, duration, and aggravation by routine physical activity), MHD, MMD, AMD, whether patients had MOH or not, associated symptoms (photophobia, phonophobia, and nausea/vomiting), treatment (triptan response and total prior failures), other scores (GAD-7 and PHQ-9), medical history (psychiatric, gastrointestinal, vascular, hormonal, cancer, respiratory, or immuno-rheumatologic), and family history of headache. Triptan response was defined as how many times triptan successfully relieved a headache out of three usages.
Publication 2023
Diagnosis Headache Hematologic Neoplasms Index, Body Mass Migraine Disorders Nausea Patients Phonophobia Photophobia Respiratory Rate Severity, Pain Triptans
Participants were considered to have a PTH if they endorsed a headache sometimes or often on the HBI17 (link) within 10 days after injury. Headaches were classified into 1 of 4 mutually exclusive phenotype groups according to modified International Classification of Headache Disorders, 3rd Edition (ICHD-3)20 (link) clinical criteria, based on self-reported symptoms: (1) PTH-M: participant with concussion endorsed PTH on the HBI17 (link) and nausea or both photophobia and phonophobia on the Postconcussion Symptom Interview18 (link); (2) PTH-NM: participant with concussion endorsed PTH that did not include migraine characteristics; (3) no PTH: participant with concussion endorsed PTH never or rarely, regardless of whether they endorsed nausea, photophobia, or phonophobia; (4) OI: participant with OI met the criteria for no PTH.
Publication 2023
Brain Concussion Headache Headache Disorders Injuries Migraine Disorders Nausea Phenotype Phonophobia Photophobia Post-Concussion Syndrome
The LDB test allow to monitor photophobic behavior which is common behavior seen in migraine patients during attacks (43 (link)). Rats were individually tested in the LDB test on day 4 post-surgery. Rats in their cages were placed in the testing room around 9:30 a.m. for acclimatization, and testing were held between 10 and 12 a.m.
The setup consisted of two plexiglas boxes of identical size (50 × 50 cm and 34 cm in height). The light box had no lid and a light intensity of ~1,000 lux. This specific light intensity was chosen to stimulate a lighter environment, that would discourage rats that experience photophobia, while not discouraging healthy rats to explore. The second box consisted of darker walls and a top to make it pitch-dark, with plexiglass permeable to infra-red (IR) light, making video-recordings possible. A darker environment is believed to be more suitable for rats experiencing photophobia. There was an opening of 10 × 10 cm between the two boxes to facilitate transition between the boxes for the rats.
Rats were taken individually out of their cages and placed in the center of the light box with their heads facing away from the dark box. Rats were recorded and tracked using the ANY-MAZE (Stoetling, USA) software and an IR lamp to monitor their behavior. Time spent in the light zone (seconds) was chosen as parameter for analysis of photophobic behavior. Distance traveled per minute spent in the dark box was a parameter chosen for the reduced physical activity migraineurs experience during migraine attacks. The individual rats were monitored for 10 min. When testing was completed for each rat, both boxes were cleaned with 20% ethanol to remove scent of previous rats to avoid discrepancies and distractions between tests. The investigator was blinded to the group designation.
Publication 2023
Acclimatization ARID1A protein, human Darkness Ethanol Head Infrared Rays Light MAZE protocol Migraine Disorders Neoplasm Metastasis Patients Permeability Pheromone Photophobia Plexiglas Rattus norvegicus Surgery, Day Vision
For a recorded afferent fiber, its mechanosensitive receptive field in the hindpaw glabrous skin was first searched using a glass rod. Poking with the glass rod at the mechanosensitive receptive field of the recorded afferent fiber would result in the detection of APs by the recording electrode. In the present study, all data were collected from mechanosensitive receptive sites, i.e., mechanoreceptors in the hindpaw glabrous skin. Once a mechanoreceptor was identified, mechanical stimulation was applied to the same receptive field with a force-calibrated mechanical indenter (300C-I, Aurora Scientific Inc., Ontario, Canada) to determine mechanical thresholds. The tip size of the indenter was 0.8 mm in diameter. The indenter was connected to a Digidata 1550B Digitizer to allow generating ramp-and-hold mechanical stimulation using the pClamp 11 software. Prior to the application of mechanical stimulation, the tip of the indenter was lowered to the surface of the receptive field with a 10-mN force and then the 10-mN force was canceled to 0 so that the tip of the indenter was just in contact with the receptive field surface. Under the force control module, ramp-and-hold mechanical stimuli were applied to the mechanoreceptor of the glabrous skin. The step force commanders were calibrated by applying indenter at finger tips, paw pads and other areas of plantar skin, and the actual forces after the calibration were used in experiments. The ramp-and-hold force steps were at 0, 5, 30, and 80 mN. The duration of the ramp (dynamic phase) was 10 ms, and the duration of the holding (static phase) was 0.98 s. The minimal force at which AP impulses was elicited was defined as intender mechanical threshold of the mechanoreceptors. In a different set of experiments mechanical stimulation was applied using von Frey filaments to vertically poke the glabrous skin. The von Frey mechanical thresholds were determined by mechanical stimulation with von Frey filaments (0.08 ~ 6 g) onto mechanoreceptors.
To determine whether a mechanoreceptor was from Nav1.8ChR2-positive or Nav1.8ChR2-negative afferent fibers, the same mechanosensitive receptive field was stimulated by a blue LED light (Thorlab; M455L4, 455 nm) to test light sensitivity. A mechanoreceptor was from Nav1.8ChR2-positive afferent fibers if light stimulation evoked impulses. Otherwise, the mechanoreceptor was from light-insensitive or Nav1.8ChR2-negative afferent fibers. The blue Light was applied through a 40 × objective to a mechanoreceptor with a 1-s light stimulation pulse at the intensity of 50 mW. Afferent impulses evoked by mechanical and light stimulation were recorded using the pressure-clamped single-fiber recordings, and signals were amplified by the Multiclamp 700B amplifier and sampled at 25 kHz with band path filter between 0.1 Hz and 3 kHz on AC recording mode.
Publication 2023
Cytoskeletal Filaments Fibrosis Fingers Light Mechanoreceptors Photic Stimulation Photophobia Phytolacca americana Pressure Pulse Rate Skin

Top products related to «Photophobia»

Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, United Kingdom
ColorDome is a compact, self-contained laboratory instrument designed for color analysis. It provides standardized illumination and viewing conditions to accurately measure and evaluate the color properties of various samples.
Sourced in Switzerland
The μCT 35 system is a high-resolution X-ray microtomography instrument designed for non-destructive 3D imaging of small samples. It provides high-quality, high-resolution data on the internal structure and morphology of various materials and objects.
Sourced in United States, United Kingdom, Germany, Canada, Japan, Sweden, Austria, Morocco, Switzerland, Australia, Belgium, Italy, Netherlands, China, France, Denmark, Norway, Hungary, Malaysia, Israel, Finland, Spain
MATLAB is a high-performance programming language and numerical computing environment used for scientific and engineering calculations, data analysis, and visualization. It provides a comprehensive set of tools for solving complex mathematical and computational problems.
Sourced in Japan, Italy
The Horiba LB-550 is a compact and versatile laboratory equipment designed for a range of analytical applications. It features a high-precision load cell and a digital display, providing accurate measurements of sample weight. The LB-550 is suitable for use in various laboratory settings, though its specific intended use is not elaborated on.
Sourced in Morocco
Vitamin D3 is a lab equipment product manufactured by Thermo Fisher Scientific. It is a compound used for the analysis and quantification of vitamin D levels in biological samples. The core function of this product is to provide accurate and reliable results for vitamin D testing in research and clinical settings.
The AC254-060-C is a 60 mm Achromatic Lens Doublet. It is a fixed focal length lens that is designed to focus light over a broad range of wavelengths. The lens has a 60 mm diameter and a focal length of 254 mm.
The AC254-150-C is a 1-inch diameter Achromatic Doublet Lens from Thorlabs. It has a focal length of 150 mm and is designed to operate across a wide range of the visible spectrum.
The LI9830076 is a laboratory equipment product. It is designed for use in a laboratory setting, but its core function is not specified in the information provided. A more detailed and unbiased description cannot be given without additional details about the product.
Sourced in Germany, United States
The Keratograph 5M is a medical device designed for corneal topography and anterior segment analysis. It utilizes advanced imaging technology to capture comprehensive data about the surface of the eye. The Keratograph 5M provides detailed information about the curvature and shape of the cornea, which is essential for various ophthalmic applications and procedures.

More about "Photophobia"

Photophobia, also known as light sensitivity or light intolerance, is a condition characterized by an abnormal and debilitating sensitivity or intolerance to light.
This condition can be caused by various underlying medical issues, such as migraines, dry eye syndrome, or other ocular disorders.
Individuals with photophobia may experience significant discomfort, pain, or even visual disturbances when exposed to bright light, whether it's natural or artificial.
Proper diagnosis and effective management of photophobia is crucial to improving the quality of life for those affected, enabling them to function comfortarby in their daily activities.
Research in this area aims to better understand the underlying mechanisms of photophobia and develop more effective treatment options.
Techniques like SAS version 9.4, ColorDome, μCT 35 system, MATLAB, and LB-550 can be utilized to study and analyze the physiological and neurological factors contributing to this condition.
Additionally, the role of Vitamin D3 (AC254-060-C, AC254-150-C, LI9830076) in photophobia has been explored, as it may have implications for both prevention and management.
The Keratograph 5M, a specialized device, can be employed to accurately assess and monitor the symptoms of photophobia, aiding in the diagnosis and tracking of the condition.
By leveraging these technologies and expanding our understanding of photophobia, researchers and healthcare professionals can work towards improving the lives of those affected by this debilitating condition.